D
Altimmune, Inc. ALT
$3.93 $0.000.00% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 10.12% 19.75% 26.74% -10.52% -53.42%
Total Depreciation and Amortization -50.82% -72.90% -71.05% 106.70% 112.08%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -24.62% 23.89% -82.94% -22.93% 24.06%
Change in Net Operating Assets -93.38% -111.57% 200.12% -224.39% 157.50%
Cash from Operations -6.86% -2.95% -10.48% -32.37% 6.58%
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 2,835.85% 87.09% 271.28% -72.76% -192.79%
Cash from Investing 2,835.58% 87.09% 271.28% -72.76% -192.70%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 19,004.55% 10,201.47% -86.14% -54.24% -98.52%
Repurchase of Common Stock 97.54% -13.00% 94.59% -100.00% 51.20%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 113,673.91% 13,172.41% -86.14% -54.76% -100.35%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 713.28% 121.69% -88.70% -65.54% -837.37%